Tag: Biogenic
Lilly drug clearly works in early-stage Alzheimer’s patients
US pharmaceutical company Eli Lilly The data underscores that earlier detection and diagnosis can really change the course of Alzheimer’s, said Anne White, Lilly’s board member, responsible for neuroscience. (Photo:…
Leqembi fully approved in the US for the first time
Frankfurt The US Food and Drug Administration (FDA) has granted full approval for the first time for a therapy that slows the progression of Alzheimer’s disease. This was announced by…
How investors are betting on innovation with pharma stocks
scientist The pharmaceutical industry is facing major development steps. (Photo: IMAGO/Westend61) Cologne According to experts, the pharmaceutical industry is on the threshold of major development steps: ever more effective drugs…
How investors are betting on innovation with pharma stocks
scientist The pharmaceutical industry is facing major development steps. (Photo: IMAGO/Westend61) Cologne According to experts, the pharmaceutical industry is on the threshold of major development steps: ever more effective drugs…
The most successful hedge fund managers rely on these stocks
Citadel CEO Ken Griffin (l.) and Greg Jansen, Bridgewater co-investment director They use different investment strategies. (Photo: Reuters, Bloomberg) Dusseldorf While US corporations are laying off employees and preparing for…
A biotech expert for Bayer: That’s how Bill Anderson ticks
Bill Anderson The former Roche pharmaceutical boss will become the new CEO of Bayer. (Photo: dpa) Zurich, Dusseldorf “I couldn’t be happier to join Team Bayer.” That was the first…
A biotech expert for Bayer: That’s how Bill Anderson ticks
Bill Anderson The former Roche pharmaceutical boss will become the new CEO of Bayer. (Photo: dpa) Zurich, Dusseldorf “I couldn’t be happier to be joining Team Bayer.” That was the…
Strong gains on Wall Street – Curevac shares gain more than 23 percent
new York A solid US jobs report amid easing wage pressures has allayed interest rate worries on Wall Street. The Dow Jones index of standard values closed 2.1 percent higher…
FDA grants preliminary approval for new Alzheimer’s drug
Frankfurt On Friday evening, the American drug agency FDA granted preliminary approval for the new Alzheimer’s drug lecanemab, thereby raising hopes for further progress in the fight against dementia. The…
Fed Chair Powell unleashes price fireworks on Wall Street
new York It was the confirmation that many investors had hoped for: The US Federal Reserve (Fed) wants to slow down the pace of interest rate hikes, announced Fed Chairman…
Investors on Wall Street are stepping on the brakes
New York Stock Exchange Investors held back on Wall Street. (Photo: AP) new York Investors on Wall Street started the week down after the recent rally. The Dow Jones index…
Alzheimer’s drug gantenerumab disappointed in clinical studies
Roche building The Swiss have suffered another setback in Alzheimer’s research. (Photo: RERUTERS) Zurich The pharmaceutical company Roche and its German partner Morphosys have to accept a new setback in…
Alzheimer’s drug gantenerumab disappointed in clinical studies
Roche building The Swiss have suffered another setback in Alzheimer’s research. (Photo: RERUTERS) Zurich The pharmaceutical company Roche and its German partner Morphosys have to accept a new setback in…
Roche’s Alzheimer’s drug disappoints in clinical trials
Roche building The Swiss have suffered another setback in Alzheimer’s research. (Photo: RERUTERS) Zurich The Swiss pharmaceutical giant Roche has to cope with another research setback with a new Alzheimer’s…
Biotech stocks are interesting for investors
Blood cancer cells and immunoglobins The biotech company Amgen develops therapies against cancer. In late August, Amgen’s stock rose 7 percent after it acquired another biotech company. (Photo: obs) Cologne…
US stock exchanges end trading day in positive territory – Biogen shares rise by up to 43 percent
Dealers in New York The nervousness on the international financial markets is currently high. (Photo: Reuters) new York After several days of losses in a row, investors are returning to…
New data from drug research expected in autumn
Alzheimer’s disease Protein deposits in the brain – so-called amyloid plaques – are one of the main characteristics of Alzheimer’s disease. Many of the drug candidates currently being researched aim…
Alzheimer’s researcher Sylvain Lesné under suspicion of forgery
Frankfurt When Sylvain Lesné published a widely acclaimed study on a possible central cause of Alzheimer’s disease in the journal “Nature” 16 years ago, he, the main author, was just…
Group invests billions in the healthcare business
Fuji building in Tokyo The technology group has great ambitions in the healthcare market. (Photo: mauritius images / Askar Karimullin / Alamy / Alamy Stock Photos) Dusseldorf Photographic film was…
Eli Lilly is the new star of the pharmaceutical industry
Frankfurt In the past two years, the headlines in the pharmaceutical industry have been dominated by the American industry leader Pfizer with its Covid vaccine Comirnaty – developed together with…